Liver cancer was the second major killer in Taiwan in 2014 while chronic hepatitis and hardening of the liver ranked at 9th among the major causes of death among patients.
Each year, 13,000 hepatitis B and hepatitis C patients die from their disease. There is an estimated 1,000,000 chronic hepatitis B patients on Taiwan but only 170,000 are receiving treatment. The reasons for such a low treatment rate, according to Taiwanese doctors, are (1) hepatitis B does not cause pain therefore the “patients” do not think they need to be checked out nor need medical treatment, and (2) 50% of people with hepatitis B do not even realize that they have hepatitis B.
There are an estimated 2,000,000 to 2,350,000 hepatitis B carriers, and there are 400,000 to 600,000 hepatitis C patients, also, there is an estimated 1,000,000 people who do not even know that they have hepatitis B and or hepatitis C.
The risk of getting liver cancer among hepatitis B carriers is 60 times those who are not carriers, and the risk of getting liver cancer among hepatitis B carriers who smoke and drink is 120 times that of the general population.